Capital International Ltd. CA increased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 14.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,479 shares of the financial services provider's stock after buying an additional 6,953 shares during the period. Capital International Ltd. CA's holdings in CME Group were worth $12,652,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. SJS Investment Consulting Inc. grew its holdings in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock valued at $26,000 after buying an additional 97 shares during the period. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the last quarter. Financial Life Planners purchased a new stake in CME Group in the fourth quarter valued at approximately $32,000. Knuff & Co LLC acquired a new position in CME Group during the fourth quarter worth approximately $33,000. Finally, Fortitude Family Office LLC raised its stake in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock worth $35,000 after purchasing an additional 83 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Activity
In other CME Group news, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 27,076 shares of company stock worth $6,871,496. 0.30% of the stock is currently owned by insiders.
Analyst Ratings Changes
Several analysts have recently issued reports on the stock. Morgan Stanley raised shares of CME Group from an "equal weight" rating to an "overweight" rating and set a $301.00 price objective for the company in a research note on Tuesday, April 8th. JPMorgan Chase & Co. boosted their price target on CME Group from $209.00 to $212.00 and gave the company an "underweight" rating in a research report on Thursday, February 13th. Citigroup downgraded CME Group from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Finally, Bank of America increased their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, CME Group currently has an average rating of "Hold" and an average target price of $247.47.
View Our Latest Research Report on CME Group
CME Group Stock Performance
CME Group stock opened at $262.53 on Friday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $273.42. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The company has a market capitalization of $94.60 billion, a price-to-earnings ratio of 27.15, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The firm's fifty day moving average price is $256.78 and its 200 day moving average price is $240.16.
CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. This is a positive change from CME Group's previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. CME Group's dividend payout ratio is presently 51.71%.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.